3
Announcements
Trials
Browse
Landscape
Status
Completed
3
Unknown
1
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
33
Gynecologic
7
Thoracic
6
Head & Neck
6
Genitourinary
6
Sarcoma
4
Dermatologic
4
Breast
4
NET
3
Endocrine
3
Other solid neoplasm
2
Other hematologic neoplasm
2
CNS
2
Plasma cell
1
Conditions
Multiple Myeloma
491
Lymphoma
53
Recurrence
49
Neoplasms, Plasma Cell
49
Immunoglobulin Light-chain Amyloidosis
42
Neoplasms
36
Lymphoma, Non-Hodgkin
35
Leukemia
35
Hematologic Neoplasms
31
Myelodysplastic Syndromes
28
Smoldering Multiple Myeloma
27
Leukemia, Myeloid, Acute
26
Leukemia, Plasma Cell
23
Precursor Cell Lymphoblastic Leukemia-Lymphoma
21
Monoclonal Gammopathy of Undetermined Significance
18
Hodgkin Disease
18
Amyloidosis
18
Leukemia, Lymphocytic, Chronic, B-Cell
17
Lymphoma, B-Cell
15
Breast Neoplasms
14
Ovarian Neoplasms
12
Paraproteinemias
11
Myeloproliferative Disorders
10
Colorectal Neoplasms
10
Primary Myelofibrosis
9
Melanoma
9
Lymphoma, Follicular
9
Infections
9
Prostatic Neoplasms
8
Lymphoproliferative Disorders
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Gallbladder Neoplasms
×
Plasma cell
×
Clear all
NCT02012699
2026-05-05
iCaRe2
University of Nebraska
Recruiting
999,999 enrolled